Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi Vessel Coronary Artery Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00165035
What this trial is testing

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Who this might be right for
Coronary Disease
Cordis US Corp. 1,701
Post-approval studies (Phase 4)Study completedNCT04665648
What this trial is testing

Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention

Who this might be right for
ST Elevation Myocardial InfarctionPercutaneous Coronary Intervention
Fudan University 1,500
Post-approval studies (Phase 4)Study completedNCT00319449
What this trial is testing

Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

Who this might be right for
HypercholesterolemiaCoronary Arteriosclerosis
Organon and Co 22
Not applicableActive Not RecruitingNCT05205499
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Biotyx Medical (Shenzhen) Co., Ltd. 1,059
Not applicableUnknownNCT01035034
What this trial is testing

Comparison of One-stop Hybrid Revascularization Versus Percutaneous Coronary Intervention for the Treatment of Multi-vessel Disease

Who this might be right for
Coronary Artery Disease
China National Center for Cardiovascular Diseases 480
Not applicableStudy completedNCT02542007
What this trial is testing

Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

Who this might be right for
Coronary Arteriosclerosis
OrbusNeich 440
Not applicableEnded earlyNCT03484234
What this trial is testing

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)

Who this might be right for
Coronary Artery DiseaseCoronary Stenosis
Seung-Jung Park 36
Testing effectiveness (Phase 2)Ended earlyNCT01863225
What this trial is testing

Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia

Who this might be right for
DyslipidemiaCoronary Artery Disease
Resverlogix Corp 13
Not applicableStudy completedNCT04272060
What this trial is testing

Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease

Who this might be right for
Coronary Artery Disease
Johns Hopkins University 175
Not applicableStudy completedNCT04255043
What this trial is testing

Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon

Who this might be right for
Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University 260
Large-scale testing (Phase 3)Study completedNCT07146360
What this trial is testing

Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction

Who this might be right for
Myocardial Infarction (MI)
AO GENERIUM 180
Not applicableStudy completedNCT01860079
What this trial is testing

Early Discharge After Primary Percutaneous Coronary Intervention

Who this might be right for
ST Elevation Myocardial Infarction
Acibadem University 900
Testing effectiveness (Phase 2)Study completedNCT03470441
What this trial is testing

Acute Myocardial Infarction Using FDY-5301

Who this might be right for
Acute Myocardial InfarctionSTEMI
Faraday Pharmaceuticals, Inc. 120
Large-scale testing (Phase 3)UnknownNCT02448524
What this trial is testing

Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)

Who this might be right for
Coronary Heart Disease
Micell Technologies 428
Not applicableEnrolling By InvitationNCT06025305
What this trial is testing

Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography

Who this might be right for
Coronary Artery DiseasePlaque, Atherosclerotic
Jinling Hospital, China 2,000
Post-approval studies (Phase 4)Study completedNCT01396395
What this trial is testing

Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina

Who this might be right for
Stable AnginaCoronary Disease
Merck KGaA, Darmstadt, Germany 402
Not applicableUnknownNCT06172985
What this trial is testing

A CCTA Image Assisted Triage Software for the Assessment of Patients With Suspected Coronary Artery Disease

Who this might be right for
Coronary Heart Disease
Keya Medical 1,093
Not applicableStudy completedNCT01196819
What this trial is testing

Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

Who this might be right for
Coronary Artery Disease
Shanghai MicroPort Medical (Group) Co., Ltd. 458
Post-approval studies (Phase 4)UnknownNCT03287167
What this trial is testing

Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Who this might be right for
Coronary DiseaseDrug Eluting StentPercutaneous Coronary Intervention+1 more
Shanghai MicroPort Medical (Group) Co., Ltd. 1,720
Post-approval studies (Phase 4)Study completedNCT00295191
What this trial is testing

Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)

Who this might be right for
End-stage Renal DiseaseHemodialysis
Ege University 704
Next Page